NCT02539628View on ClinicalTrials.gov

Adductor Canal Block With Continuous Infusion Versus Intermittent Boluses and Morphine Consumption

PHASE4CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Postoperative Pain
Interventions
DRUG

ropivacaine 0.2%

Adductor canal block. Placed immediately postoperative. Intervention stops on POD2 12PM

Trial Locations (1)

2900

Department of Anaesthesia-Surgery-Intensive Care, Gentofte Hospital, Gentofte Municipality

All Listed Sponsors
collaborator

University of California, San Diego

OTHER

collaborator

Bispebjerg Hospital

OTHER

collaborator

Smiths Medical, ASD, Inc.

INDUSTRY

lead

Pia Jaeger

OTHER

NCT02539628 - Adductor Canal Block With Continuous Infusion Versus Intermittent Boluses and Morphine Consumption | Biotech Hunter | Biotech Hunter